Floatz logo

ABOBOTULINUMTOXINA

Spasticity, Muscle

Neurology Center of New England P.C.protein_peptidePhase 3Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Spasticity, Muscle cohort.

Asset / SponsorPhaseRating
Meditoxin
Medy-Tox
Phase 4BB
Arbaclofen
RVL Pharmaceuticals, Inc.
Phase 3BB
Xeomin®
Sisli Hamidiye Etfal Training and Research Hospital
Phase 4BB
Bont A
Kayseri City Hospital
N/AD
AUTOLOGOUS CONDITIONED PLASMA
Ege University
N/AD

Same molecule, other indications

ABOBOTULINUMTOXINA is also rated in:

compartment syndromeDormant
B
Indicative ·
56 / 100
View asset →
PainDormant
CC
Indicative ·
47 / 100
View asset →
Lower Back PainDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →